Therapeutic Strategies for Heart Failure 2018
Heart failure (HF) is the most important burden of the cardiovascular field in the world. Unfortunately, no drug has been developed over the past several decades regarding the improvement of outcome in patients with Heart failure for hospitalization (HHF).
What are the reasons for it? One of the reasons is that pathophysiological conditions of HF had not been fully understood.Therapeutic Strategies for Heart Failure 2018 pdf provides the basic knowledge about the pathology and treatment protocol of heart failure in 2018.
Given the increasing incidence and prevalence of HHF, we live in a world facing a Heart Failure pandemic. As one of the countries with outstanding longevity, Japan has unique characteristics concerning the selection of medical therapies, diagnostic techniques, team-managing, and other treatments.
The present Therapeutic Strategies for Heart Failure 2018 book was written by HF experts in Japan, who have discussed with each other the pathophysiology and management for HF based on pieces of evidence and their own clinical experiences.
This Therapeutic strategy for Heart Failure 2018 present book was written as our integrated achievement and explains current understanding of HF pathophysiology and management from comprehensive views. The theme of each chapter was decided by each HF expert.
The contents included the concept of HF and treatments from acute to chronic phases, HF management guided by the B-type natriuretic peptide, the idea of congestion and the importance of early intervention for congestion, pharmacological and non-pharmacological management for refractory HF, and multidisciplinary approaches for end-stage HF including palliative care.
Author primary aim in the Therapeutic Strategies for Heart Failure 2018 textbook was to provide the current understanding of Heart Failure from the viewpoints of Japanese HF experts. To improve management of HF, we
should always consider pathophysiology and appropriate therapies for it. It means that accurate evaluation of the pathophysiological condition of HF patients is the most important to manage them.